Aperture Venture Partners is a New York-based venture capital firm that primarily invests in early-stage and venture capital opportunities within the healthcare industry. Their focus areas include medical devices, pharmaceuticals, healthcare IT/services, and diagnostics.
Portfolio
8
Fund Size
—
Top Stage
Series C
Last 12 Mo
3
Stage Distribution
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Ex Nunc Intelligence | Pre-Seed | $2.1M | Jan 2026 |
| Neuros Medical | Series D | $56M | Jul 2025 |
| Shoulder Innovations | Series E | $40M | Mar 2025 |
| Cortica, Inc. | Growth | $75M | Apr 2023 |
| Cortica, Inc. | Series C | $60M | Jun 2021 |
| V-Wave Ltd. | Series C | $98M | Sep 2020 |
| Tarsus Pharmaceuticals | Series B | $60M | Jan 2020 |
| ShiraTronics, Inc. | Series A | $33M | Oct 2019 |
Top Co-Investors
Longitude Capital2 shared
.406 Ventures2 shared
Deerfield2 shared
U.S. Venture Partners2 shared
Amzak Health2 shared
Sectoral Asset Management2 shared
Silicon Valley Bank1 shared
Endeavour Vision1 shared
Pontifax1 shared
Pura Vida Investments1 shared
TriVentures1 shared
EQT Life Sciences1 shared
Osage University Partners1 shared
Gilde Healthcare1 shared
Gilmartin Capital1 shared
USVP1 shared
Optum Ventures1 shared
RA Capital Management1 shared
Ajax Health1 shared
Vivo Capital1 shared
Last updated: 3 March 2026